Cosmos Health Inc [COSM] stock prices are up 0.07% to $0.67 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The COSM shares have gain 8.25% over the last week, with a monthly amount drifted -16.27%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Cosmos Health Inc [COSM] has been fluctuating between $0.47 and $1.58 over the past year. Cosmos Health Inc [NASDAQ: COSM] shares were valued at $0.67 at the most recent close of the market.
Analyzing the COSM fundamentals
The Cosmos Health Inc [NASDAQ:COSM] reported sales of 53.38M for trailing twelve months, representing a surge of 0.39%. Gross Profit Margin for this corporation currently stands at 0.08% with Operating Profit Margin at -0.36%, Pretax Profit Margin comes in at -0.36%, and Net Profit Margin reading is -0.36%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.59 and Total Capital is -0.51. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6368 points at the first support level, and at 0.6046 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6951, and for the 2nd resistance point, it is at 0.7212.
Ratios To Look Out For
It’s worth pointing out that Cosmos Health Inc [NASDAQ:COSM]’s Current Ratio is 1.44. As well, the Quick Ratio is 1.24, while the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 0.29, the price to book ratio is 0.44.
Transactions by insiders
Recent insider trading involved Terzis Georgios, Chief Financial Officer, that happened on Dec 20 ’24 when 85778.0 shares were purchased. Chief Executive Officer, Siokas Grigorios completed a deal on Dec 20 ’24 to buy 0.26 million shares. Meanwhile, Chief Executive Officer Siokas Grigorios bought 60000.0 shares on Feb 16 ’24.
